Literature DB >> 23891089

Residual γH2AX foci predict local tumour control after radiotherapy.

Ulrike Koch1, Katharina Höhne, Cläre von Neubeck, Howard D Thames, Ala Yaromina, Jochen Dahm-Daphi, Michael Baumann, Mechthild Krause.   

Abstract

PURPOSE: Evaluation of micromilieu-dependent quantified γH2AX foci as a potential predictive biomarker in well-oxygenated tumour areas in 9 HNSCC xenograft models in vivo. MATERIALS &
METHODS: GammaH2AX foci were quantified in perfused tumour areas 30 min (initial γH2AX foci) and 24 h (residual γH2AX foci) after exposure to a single dose of 4 Gy. The initial and residual normalised γH2AX foci were correlated with TCD50 after single dose irradiation under clamped blood flow (SDclamp) or a fractionated irradiation setting under ambient blood flow (fx).
RESULTS: A significant negative correlation between initial and residual normalised γH2AX foci and TCD50 SDclamp and TCD50 fx for 9 HNSCC tumour xenograft models in vivo was found. Residual normalised γH2AX foci showed higher intertumoural variability and their correlation with TCD50 was more robust.
CONCLUSIONS: For the first time a significant negative correlation between γH2AX foci and local tumour control after irradiation has been demonstrated. Our results underline the potential of residual γH2AX foci as a predictive biomarker for local tumour control after radiotherapy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarker; DNA repair; Local tumour control; Radiotherapy; Tumour micromilieu; γH2AX

Mesh:

Substances:

Year:  2013        PMID: 23891089     DOI: 10.1016/j.radonc.2013.06.022

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

Review 1.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

Review 2.  Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Authors:  C Norman Coleman; Geoff S Higgins; J Martin Brown; Michael Baumann; David G Kirsch; Henning Willers; Pataje G S Prasanna; Mark W Dewhirst; Eric J Bernhard; Mansoor M Ahmed
Journal:  Clin Cancer Res       Date:  2016-05-06       Impact factor: 12.531

Review 3.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

4.  Dynamic In Vivo Profiling of DNA Damage and Repair after Radiotherapy Using Canine Patients as a Model.

Authors:  Nadine Schulz; Hassan Chaachouay; Katarzyna J Nytko; Mathias S Weyland; Malgorzata Roos; Rudolf M Füchslin; Franco Guscetti; Stephan Scheidegger; Carla Rohrer Bley
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

5.  Modeling the Effect of Hypoxia and DNA Repair Inhibition on Cell Survival After Photon Irradiation.

Authors:  Hans Liew; Carmen Klein; Frank T Zenke; Amir Abdollahi; Jürgen Debus; Ivana Dokic; Andrea Mairani
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

6.  Evaluation of Capability and Relationship of Different Radiobiological Endpoints for Radiosensitivity Prediction in Human Tumor Cell Lines Compared with Clonogenic Survival.

Authors:  Fatemeh Pakniyat; Hassan Ali Nedaie; Hossein Mozdarani; Aziz Mahmoudzadeh; Somayeh Gholami
Journal:  J Biomed Phys Eng       Date:  2022-04-01

Review 7.  Novel Biological Approaches for Testing the Contributions of Single DSBs and DSB Clusters to the Biological Effects of High LET Radiation.

Authors:  Veronika Mladenova; Emil Mladenov; George Iliakis
Journal:  Front Oncol       Date:  2016-06-28       Impact factor: 6.244

8.  Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams.

Authors:  Ivana Dokic; Andrea Mairani; Martin Niklas; Ferdinand Zimmermann; Naved Chaudhri; Damir Krunic; Thomas Tessonnier; Alfredo Ferrari; Katia Parodi; Oliver Jäkel; Jürgen Debus; Thomas Haberer; Amir Abdollahi
Journal:  Oncotarget       Date:  2016-08-30

9.  Heterogeneity of γH2AX Foci Increases in Ex Vivo Biopsies Relative to In Vivo Tumors.

Authors:  Treewut Rassamegevanon; Steffen Löck; Michael Baumann; Mechthild Krause; Cläre von Neubeck
Journal:  Int J Mol Sci       Date:  2018-09-04       Impact factor: 5.923

10.  CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma.

Authors:  Pierre Philouze; Arnaud Gauthier; Alexandra Lauret; Céline Malesys; Giovanna Muggiolu; Sylvie Sauvaigo; Antoine Galmiche; Philippe Ceruse; Gersende Alphonse; Anne-Sophie Wozny; Claire Rodriguez-Lafrasse
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.